Publications by authors named "Lingjun Feng"

Claim this Profile
P
Primary squamous thyroid cancer: A case report.
Shuchang Dong, Xuewen Wang, Ziwen Zhou, Lingjun Feng, Qingliang Xu

Oncol Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis.
Ting Song, Lingjun Feng, Yulei Xia, Meng Pang, Jianhong Geng

Front Neurol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of LIG1 and LIG3 as prognostic biomarkers in breast cancer.
Lin Sun, Xinyu Liu, Siqi Song, Lingjun Feng, Chunying Shi

Open Med (Wars)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Alterations and Potential Roles of MCMs in Breast Cancer.
Xinyu Liu, Ying Liu, Qiangshan Wang, Siqi Song, Lingjun Feng

J Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Method for Detecting the Suppressing Effect of Enzyme Activity by Aminopeptidase N Inhibitor.
Huijie Liu, Xuejuan Wang, Hanlin Yang, Yan Zhao, Shengping Ji, Lingjun Feng

Chem Pharm Bull (Tokyo)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue microRNA-182 expression level and its potential prognostic value for papillary thyroid carcinoma.
Xing-Guo Yao, Qiang Tan, Ping-Ping Liu, Ling-Jun Feng

Int J Clin Exp Pathol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Phosphodiesterase-2A Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay.
Chen Zhang, Ling-Jun Feng, Yiyou Huang, Deyan Wu, Zhe Li

J Chem Inf Model· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-374T/A polymorphism of the receptor for advanced glycation end products is associated with decreased risk of breast cancer in a Chinese population.
Ling-Jun Feng, Hong-Ling Liu, Qiang Tan, Peng Jin

Int J Clin Exp Med· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds.
Zhe Li, Xiao Lu, Ling-Jun Feng, Ying Gu, Xingshu Li

Mol Biosyst· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palladium-catalyzed oxidative C-H bond acylation of N-nitrosoanilines with toluene derivatives: a traceless approach to synthesize N-alkyl-2-aminobenzophenones.
Yinuo Wu, Ling-Jun Feng, Xiao Lu, Fuk Yee Kwong, Hai-Bin Luo

Chem Commun (Camb)· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a phosphodiesterase 9A inhibitor as a potential hypoglycemic agent.
Yong-xian Shao, Manna Huang, Wenjun Cui, Ling-Jun Feng, Yinuo Wu

J Med Chem· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ab Initio QM/MM Study Shows a Highly Dissociated SN2 Hydrolysis Mechanism for the cGMP-Specific Phosphodiesterase-5.
Zhe Li, Yinuo Wu, Ling-Jun Feng, Ruibo Wu, Hai-Bin Luo

J Chem Theory Comput· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study.
Yi-You Huang, Zhe Li, Ying-Hong Cai, Ling-Jun Feng, Yinuo Wu

J Chem Inf Model· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis